BGM0504 Tablets

· BrightGene Bio-Medical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGM0504 Tablets, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects [Phase 1]

See pricing